APO-GLIMEPIRIDE TABLET Canada - English - Health Canada

apo-glimepiride tablet

apotex inc - glimepiride - tablet - 4mg - glimepiride 4mg - sulfonylureas

MIRVALA 21 TABLET Canada - English - Health Canada

mirvala 21 tablet

apotex inc - desogestrel; ethinyl estradiol - tablet - 0.1500mg; 0.0300mg - desogestrel 0.1500mg; ethinyl estradiol 0.0300mg - contraceptives

MIRVALA 28 TABLET Canada - English - Health Canada

mirvala 28 tablet

apotex inc - desogestrel; ethinyl estradiol - tablet - 0.1500mg; 0.0300mg - desogestrel 0.1500mg; ethinyl estradiol 0.0300mg - contraceptives

APO-GLICLAZIDE MR  30mg tablets, bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apo-gliclazide mr 30mg tablets, bottle

arrotex pharmaceuticals pty ltd - gliclazide, quantity: 30 mg - tablet, modified release - excipient ingredients: stearic acid; hypromellose; colloidal anhydrous silica - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose. during controlled clinical trials in patients with type ii diabetes, gliclazide mr 30 mg tablets, taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.

APO-GLICLAZIDE MR  30mg tablets, blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-gliclazide mr 30mg tablets, blister pack

arrotex pharmaceuticals pty ltd - gliclazide, quantity: 30 mg - tablet, modified release - excipient ingredients: hypromellose; stearic acid; colloidal anhydrous silica - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose. during controlled clinical trials in patients with type ii diabetes, gliclazide mr 30 mg tablets, taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.

GLYADE MR gliclazide 30mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

glyade mr gliclazide 30mg tablet blister pack

servier laboratories (aust) pty ltd - gliclazide, quantity: 30 mg - tablet, modified release - excipient ingredients: colloidal anhydrous silica; maltodextrin; magnesium stearate; hypromellose; calcium hydrogen phosphate dihydrate - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.